Laza Medical Raises Up to $160 Million in Series B Financing Led by GE HealthCare to Advance Intelligent Imaging for Transforming the Cath Lab
Article excerpt
Highlighted: the sentence this signal was extracted from
Company's first-of-a-kind intelligent imaging system aims to expand patient access, streamline high-quality cardiac care, and establish the foundation for future robotic interventions LOS GATOS, Calif., Nov. 4, 2026 /PRNewswire/ -- Laza Medical, Inc., a Shifamed portfolio company pioneering AI-powered robotic imaging solutions for cardiac interventions, today announced it has raised up to $160 million in Series B structured financing. GE HealthCare led the round, with participation from returning investors Unorthodox Ventures, PA MedTech, and AMED. The financing will support the company's mission to transform the cardiac catheterization laboratory through intelligent imaging technology designed to simplify procedures, increase autonomy, alleviate resource constraints, and unlock the possibilities for future robotic-enabled interventions. "The future of cardiac intervention must be one where access, consistency, and quality of care are no longer barriers to better outcomes," stated Jyoti Gera, CEO of Cardiovascular and Interventional Solutions, Advanced Imaging Solutions at GE HealthCare. "Integrating imaging modalities so they work seamlessly together has the potential to redefine the cath lab, enabling more efficient workflows today and paving the way for smarter, robotic procedures tomorrow. We're excited to expand our collaboration with Laza and work together toward...
Keep reading with a free account
The rest of this article, and every signal for GE HealthCare, is in your free account.
